Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD

NCT05912218 is registered in ClinicalTrials.gov with National Heart Centre Singapore as lead sponsor.

NCT NCT05912218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD
Lead sponsor
National Heart Centre Singapore
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 2, 2023
Completion date
December 1, 2025
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, peripheral arterial disease